• Minimize risk and seize opportunities

  • Drug development has never faced more challenges: Increasing costs, growing complexity, longer timelines. Count on Quintiles’ systems, processes and expertise to help you navigate every step.

    • Ensure your trial gets off to the right start with the best possible operational strategy
    • Keep your trial on course with clinical trial management that delivers the efficiencies, rigor, and scale you need
    • Finish strong with a quality NDA submission built on smarter data collection, interpretation and reporting
  • Our Perspectives 

    slider image

    EIU Emerging China

    This Economist Intelligence Unit study, sponsored by Quintiles, looks at China’s growing pharmaceutical market and its implications for the global life sciences sector. Read white paper here

    slider image

    Lifecycle Modeling and Simulation

    Modeling and simulation is poised to transform drug development across the entire lifecycle from discovery to commercialization. Read white paper here

    slider image

    Integration of Molecular Biomarkers into Clinical Development

    Quintiles experts in strategic drug development recommend using biomarkers in anti-cancer therapy research.  Read white paper here

  •  
     
     

    Video Spotlights 

  • Position your clinical trial for success -  from the start

    Quintiles
    Increase your chances of regulatory approval by 11% - with clinical development insights from Quintiles.

    Conducting trials proactively requires immediate decisions about safety, productivity, costs and risks. Read more

    80% of clinical trials don’t meet enrollment deadlines. But you can change those odds with streamlined site selection and patient recruitment. Find out how

    Test-drive your trial to determine the most effective solution before making a huge investment. Learn more

  • Quintiles Clinical Trails

  • Featured News

    Quintiles’ First Quarter 2014 Earnings Call Scheduled for Thursday, May 1st
    Read more

    Quintiles Appoints Dr. Stella Blackburn to Lead Global Risk Management
    Read more

    Quintiles Announces Exercise of the Underwriters’ Option to Purchase Additional Secondary Shares
    Read more

    Our Perspectives

    The Collaboration Mandate
    Read more

    Partnerships, Patients and Proof
    Read more

    Biomarkers: Recent Advances in their Application to the Treatment of Hematologic Malignancies
    Read more